Pilgrim's Pride (PPC) Competitors

MEDIFAST (NYSE:MED) and Pilgrim's Pride (NASDAQ:PPC) are both consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Which has more risk & volatility, MED or PPC?

MEDIFAST has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Pilgrim's Pride has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.

Does the media favor MED or PPC?

In the previous week, Pilgrim's Pride had 10 more articles in the media than MEDIFAST. MarketBeat recorded 11 mentions for Pilgrim's Pride and 1 mentions for MEDIFAST. Pilgrim's Pride's average media sentiment score of 1.27 beat MEDIFAST's score of 0.00 indicating that Pilgrim's Pride is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MEDIFAST	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pilgrim's Pride	8 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in MED or PPC?

95.5% of MEDIFAST shares are owned by institutional investors. Comparatively, 16.6% of Pilgrim's Pride shares are owned by institutional investors. 2.9% of MEDIFAST shares are owned by company insiders. Comparatively, 82.6% of Pilgrim's Pride shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Do analysts rate MED or PPC?

MEDIFAST presently has a consensus target price of $16.50, indicating a potential upside of 32.50%. Pilgrim's Pride has a consensus target price of $47.67, indicating a potential upside of 26.74%. Given MEDIFAST's higher probable upside, analysts plainly believe MEDIFAST is more favorable than Pilgrim's Pride.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MEDIFAST	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Pilgrim's Pride	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.83

Which has higher earnings and valuation, MED or PPC?

Pilgrim's Pride has higher revenue and earnings than MEDIFAST. Pilgrim's Pride is trading at a lower price-to-earnings ratio than MEDIFAST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MEDIFAST	$602.46M	0.23	$2.09M	$0.32	38.92
Pilgrim's Pride	$17.88B	0.50	$1.09B	$5.19	7.25

Is MED or PPC more profitable?

Pilgrim's Pride has a net margin of 6.81% compared to MEDIFAST's net margin of 0.76%. Pilgrim's Pride's return on equity of 37.15% beat MEDIFAST's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MEDIFAST	0.76%	2.00%	1.50%
Pilgrim's Pride	6.81%	37.15%	13.46%

Summary

Pilgrim's Pride beats MEDIFAST on 11 of the 15 factors compared between the two stocks.